|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:UBAP2-USP34 (FusionGDB2 ID:95945) |
Fusion Gene Summary for UBAP2-USP34 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: UBAP2-USP34 | Fusion gene ID: 95945 | Hgene | Tgene | Gene symbol | UBAP2 | USP34 | Gene ID | 55833 | 9736 |
| Gene name | ubiquitin associated protein 2 | ubiquitin specific peptidase 34 | |
| Synonyms | UBAP-2 | - | |
| Cytomap | 9p13.3 | 2p15 | |
| Type of gene | protein-coding | protein-coding | |
| Description | ubiquitin-associated protein 2AD-012 protein | ubiquitin carboxyl-terminal hydrolase 34deubiquitinating enzyme 34ubiquitin specific protease 34ubiquitin thioesterase 34ubiquitin thiolesterase 34ubiquitin-specific-processing protease 34 | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | . | . | |
| Ensembl transtripts involved in fusion gene | ENST00000360802, ENST00000379238, ENST00000418786, ENST00000449054, ENST00000480885, ENST00000539807, ENST00000379225, ENST00000379235, ENST00000379239, | ENST00000472689, ENST00000398571, | |
| Fusion gene scores | * DoF score | 17 X 13 X 10=2210 | 10 X 16 X 4=640 |
| # samples | 19 | 15 | |
| ** MAII score | log2(19/2210*10)=-3.53997504594785 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(15/640*10)=-2.09310940439148 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: UBAP2 [Title/Abstract] AND USP34 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | UBAP2(34017048)-USP34(61512092), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | UBAP2-USP34 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. UBAP2-USP34 seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | USP34 | GO:0016579 | protein deubiquitination | 14715245 |
| Tgene | USP34 | GO:0071108 | protein K48-linked deubiquitination | 21383061 |
| Tgene | USP34 | GO:0090263 | positive regulation of canonical Wnt signaling pathway | 21383061 |
| Fusion gene breakpoints across UBAP2 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across USP34 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | BRCA | TCGA-BH-A1F2-01A | UBAP2 | chr9 | 34017048 | - | USP34 | chr2 | 61512092 | - |
Top |
Fusion Gene ORF analysis for UBAP2-USP34 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5CDS-intron | ENST00000360802 | ENST00000472689 | UBAP2 | chr9 | 34017048 | - | USP34 | chr2 | 61512092 | - |
| 5CDS-intron | ENST00000379238 | ENST00000472689 | UBAP2 | chr9 | 34017048 | - | USP34 | chr2 | 61512092 | - |
| 5CDS-intron | ENST00000418786 | ENST00000472689 | UBAP2 | chr9 | 34017048 | - | USP34 | chr2 | 61512092 | - |
| 5CDS-intron | ENST00000449054 | ENST00000472689 | UBAP2 | chr9 | 34017048 | - | USP34 | chr2 | 61512092 | - |
| 5UTR-3CDS | ENST00000480885 | ENST00000398571 | UBAP2 | chr9 | 34017048 | - | USP34 | chr2 | 61512092 | - |
| 5UTR-3CDS | ENST00000539807 | ENST00000398571 | UBAP2 | chr9 | 34017048 | - | USP34 | chr2 | 61512092 | - |
| 5UTR-intron | ENST00000480885 | ENST00000472689 | UBAP2 | chr9 | 34017048 | - | USP34 | chr2 | 61512092 | - |
| 5UTR-intron | ENST00000539807 | ENST00000472689 | UBAP2 | chr9 | 34017048 | - | USP34 | chr2 | 61512092 | - |
| Frame-shift | ENST00000360802 | ENST00000398571 | UBAP2 | chr9 | 34017048 | - | USP34 | chr2 | 61512092 | - |
| Frame-shift | ENST00000418786 | ENST00000398571 | UBAP2 | chr9 | 34017048 | - | USP34 | chr2 | 61512092 | - |
| In-frame | ENST00000379238 | ENST00000398571 | UBAP2 | chr9 | 34017048 | - | USP34 | chr2 | 61512092 | - |
| In-frame | ENST00000449054 | ENST00000398571 | UBAP2 | chr9 | 34017048 | - | USP34 | chr2 | 61512092 | - |
| intron-3CDS | ENST00000379225 | ENST00000398571 | UBAP2 | chr9 | 34017048 | - | USP34 | chr2 | 61512092 | - |
| intron-3CDS | ENST00000379235 | ENST00000398571 | UBAP2 | chr9 | 34017048 | - | USP34 | chr2 | 61512092 | - |
| intron-3CDS | ENST00000379239 | ENST00000398571 | UBAP2 | chr9 | 34017048 | - | USP34 | chr2 | 61512092 | - |
| intron-intron | ENST00000379225 | ENST00000472689 | UBAP2 | chr9 | 34017048 | - | USP34 | chr2 | 61512092 | - |
| intron-intron | ENST00000379235 | ENST00000472689 | UBAP2 | chr9 | 34017048 | - | USP34 | chr2 | 61512092 | - |
| intron-intron | ENST00000379239 | ENST00000472689 | UBAP2 | chr9 | 34017048 | - | USP34 | chr2 | 61512092 | - |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000449054 | UBAP2 | chr9 | 34017048 | - | ENST00000398571 | USP34 | chr2 | 61512092 | - | 6732 | 201 | 87 | 6092 | 2001 |
| ENST00000379238 | UBAP2 | chr9 | 34017048 | - | ENST00000398571 | USP34 | chr2 | 61512092 | - | 6748 | 217 | 103 | 6108 | 2001 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000449054 | ENST00000398571 | UBAP2 | chr9 | 34017048 | - | USP34 | chr2 | 61512092 | - | 0.000274517 | 0.9997255 |
| ENST00000379238 | ENST00000398571 | UBAP2 | chr9 | 34017048 | - | USP34 | chr2 | 61512092 | - | 0.000277179 | 0.9997228 |
Top |
Fusion Genomic Features for UBAP2-USP34 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for UBAP2-USP34 |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr9:34017048/chr2:61512092) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| . | . |
| FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Tgene | USP34 | chr9:34017048 | chr2:61512092 | ENST00000398571 | 33 | 80 | 1894_2239 | 1583 | 3547.0 | Domain | Note=USP |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | UBAP2 | chr9:34017048 | chr2:61512092 | ENST00000360802 | - | 2 | 29 | 105_130 | 33 | 1120.0 | Coiled coil | Ontology_term=ECO:0000255 |
| Hgene | UBAP2 | chr9:34017048 | chr2:61512092 | ENST00000379238 | - | 2 | 29 | 105_130 | 33 | 1120.0 | Coiled coil | Ontology_term=ECO:0000255 |
| Hgene | UBAP2 | chr9:34017048 | chr2:61512092 | ENST00000449054 | - | 2 | 30 | 105_130 | 33 | 1190.6666666666667 | Coiled coil | Ontology_term=ECO:0000255 |
| Hgene | UBAP2 | chr9:34017048 | chr2:61512092 | ENST00000360802 | - | 2 | 29 | 48_92 | 33 | 1120.0 | Domain | UBA |
| Hgene | UBAP2 | chr9:34017048 | chr2:61512092 | ENST00000379238 | - | 2 | 29 | 48_92 | 33 | 1120.0 | Domain | UBA |
| Hgene | UBAP2 | chr9:34017048 | chr2:61512092 | ENST00000449054 | - | 2 | 30 | 48_92 | 33 | 1190.6666666666667 | Domain | UBA |
Top |
Fusion Gene Sequence for UBAP2-USP34 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >95945_95945_1_UBAP2-USP34_UBAP2_chr9_34017048_ENST00000379238_USP34_chr2_61512092_ENST00000398571_length(transcript)=6748nt_BP=217nt GCTTTGTAAGAGGCACATTGGCAGGTAACGAGCGGCGGCGGCGGCAGCGGGTCTTGGGTCCTCCGAGAGCAGCAGCGATTTTCTATTTTG TACATACATTATTTTGTATATACTGTATATGATGACTTCAGTGAGCAGTGACCATTGTCGAGGTGCTCGGGAAAAACCACAGATTTCAGC AGCACAATCAACGCAACCACAGAAACAAGTGGTACAGGTATTTCTTGTTCTTGTCCAAGGAACCAGTTTGATTCAGCGACTTATGTCTGT TGCTTATACGTATGATAATCTGGCTCCTAGAGTTTTAAAAGCTCAGTCTGATCACAGGTCTAGACATGAAGTTTCACATTATTCAATGTG GCTCTTGGTGAGTTGGGCTCATTGCTGTTCTTTAGTGAAATCTAGCCTTGCTGATAGCGATCATTTACAAGATTGGCTAAAGAAATTGAC TCTCCTTATTCCTGAGACTGCAGTTCGTCATGAATCATGCAGTGGTCTCTATAAGTTATCCCTGTCAGGGCTGGATGGAGGAGACTCAAT CAATCGTTCTTTTCTGCTATTGGCTGCCTCAACATTATTGAAATTTCTTCCTGATGCTCAAGCACTCAAACCTATTAGGATAGATGATTA TGAGGAAGAACCAATATTAAAACCAGGATGTAAAGAGTATTTTTGGTTGTTATGCAAATTAGTTGACAACATACATATAAAGGACGCTAG TCAGACAACGCTCCTCGACTTAGATGCCTTGGCAAGACATTTGGCTGACTGTATTCGAAGTAGGGAGATCCTTGATCATCAGGATGGTAA TGTAGAAGATGATGGGCTTACAGGACTCCTAAGGCTTGCAACAAGTGTTGTTAAACACAAACCACCCTTTAAATTTTCAAGGGAAGGACA GGAATTTTTGAGAGATATCTTCAATCTCCTGTTTTTGTTGCCAAGTCTAAAGGACCGACAACAGCCAAAGTGCAAATCACATTCTTCAAG AGCTGCCGCTTACGATTTGTTAGTAGAGATGGTAAAGGGGTCTGTTGAGAACTACAGGCTAATACACAACTGGGTTATGGCACAACACAT GCAGTCCCATGCACCTTATAAATGGGATTACTGGCCTCATGAAGATGTCCGTGCTGAATGTAGATTTGTTGGCCTTACTAACCTTGGAGC TACTTGTTACTTAGCTTCTACTATTCAGCAACTTTATATGATACCTGAGGCAAGACAGGCTGTCTTCACTGCCAAGTATTCAGAGGATAT GAAGCACAAGACCACTCTTCTGGAGCTTCAGAAAATGTTTACATATTTAATGGAGAGTGAATGCAAAGCATATAATCCTAGACCTTTCTG TAAAACATACACCATGGATAAGCAGCCTCTGAATACTGGGGAACAGAAAGATATGACAGAGTTTTTTACTGATCTAATTACCAAAATCGA AGAAATGTCTCCCGAACTGAAAAATACCGTCAAAAGTTTATTTGGAGGTGTAATTACAAACAATGTTGTATCCTTGGATTGTGAACATGT TAGTCAAACTGCTGAAGAGTTTTATACTGTGAGGTGCCAAGTGGCTGATATGAAGAACATTTATGAATCTCTTGATGAAGTTACTATAAA AGACACTTTGGAAGGTGATAACATGTATACTTGTTCTCATTGTGGGAAGAAAGTACGAGCTGAAAAAAGGGCATGTTTTAAGAAATTGCC TCGCATTTTGAGTTTCAATACTATGAGATACACATTTAATATGGTCACGATGATGAAAGAGAAAGTGAATACACACTTTTCCTTCCCATT ACGTTTGGACATGACGCCCTATACAGAAGATTTTCTTATGGGAAAGAGTGAGAGGAAAGAAGGTTTTAAAGAAGTCAGTGATCATTCAAA AGACTCAGAGAGCTATGAATATGACTTGATAGGAGTGACTGTTCACACAGGAACGGCAGATGGTGGACACTATTATAGCTTTATCAGAGA TATAGTAAATCCCCATGCTTATAAAAACAATAAATGGTATCTTTTTAATGATGCTGAGGTAAAACCTTTTGATTCTGCTCAACTTGCATC TGAATGTTTTGGTGGAGAGATGACGACCAAGACCTATGATTCTGTTACAGATAAATTTATGGACTTCTCTTTTGAAAAGACACACAGTGC ATATATGCTGTTTTACAAACGCATGGAACCAGAGGAAGAAAATGGCAGAGAATACAAATTTGATGTTTCGTCAGAGTTACTAGAGTGGAT TTGGCATGATAACATGCAGTTTCTTCAAGACAAAAACATTTTTGAACATACATATTTTGGATTTATGTGGCAATTGTGTAGTTGTATTCC CAGTACATTACCAGATCCTAAAGCTGTGTCCTTAATGACAGCAAAGTTAAGCACTTCCTTTGTCCTAGAGACATTTATTCATTCTAAAGA AAAGCCCACGATGCTTCAGTGGATTGAACTGTTGACGAAACAGTTTAATAATAGTCAGGCAGCTTGTGAGTGGTTTTTAGATCGTATGGC TGATGACGACTGGTGGCCAATGCAGATACTAATTAAGTGCCCTAATCAAATTGTGAGACAGATGTTTCAGCGTTTGTGTATCCATGTGAT TCAGAGGCTGAGACCTGTGCATGCTCATCTCTATTTGCAGCCAGGAATGGAAGATGGGTCAGATGATATGGATACCTCAGTAGAAGATAT TGGTGGTCGTTCATGTGTCACTCGCTTTGTGAGAACCCTGTTATTAATTATGGAACATGGTGTAAAACCTCACAGTAAACATCTTACAGA GTATTTTGCCTTCCTTTACGAATTTGCAAAAATGGGTGAAGAAGAGAGCCAATTTTTGCTTTCATTGCAAGCTATATCTACAATGGTACA TTTTTACATGGGAACAAAAGGACCTGAAAATCCTCAAGTTGAAGTGTTATCAGAGGAAGAAGGGGAAGAAGAAGAGGAGGAAGAAGATAT CCTCTCTCTGGCAGAAGAAAAATACAGGCCAGCTGCCCTTGAAAAGATGATAGCTTTAGTTGCTCTTTTGGTTGAACAGTCTCGATCAGA AAGGCATTTGACATTATCACAGACTGACATGGCAGCATTAACAGGAGGAAAGGGATTTCCCTTCTTGTTTCAACATATTCGTGATGGCAT CAATATAAGACAAACTTGTAATCTGATTTTCAGCCTGTGTCGATACAATAATCGACTTGCAGAACATATTGTATCTATGCTTTTCACATC AATAGCAAAGTTGACTCCTGAGGCAGCCAATCCTTTCTTTAAGTTGTTGACTATGCTAATGGAGTTTGCTGGTGGACCTCCAGGAATGCC TCCCTTTGCATCTTATATTCTGCAGAGGATATGGGAGGTGATTGAATACAATCCTTCTCAGTGTCTAGATTGGTTGGCAGTGCAGACACC CCGAAATAAACTGGCACACAGCTGGGTCTTACAGAATATGGAAAACTGGGTCGAGCGGTTTCTTTTGGCTCACAATTATCCTAGAGTGAG GACTTCTGCAGCTTATCTTCTGGTGTCCCTTATACCAAGCAATTCATTCCGTCAGATGTTCCGGTCAACAAGGTCTTTGCACATCCCAAC CCGTGACCTTCCACTCAGTCCAGACACAACAGTAGTCCTACATCAGGTCTACAACGTGCTCCTTGGTTTGCTCTCAAGAGCCAAACTTTA TGTTGATGCTGCTGTTCATGGCACTACAAAGCTAGTGCCCTATTTTAGCTTTATGACTTACTGTTTAATTTCCAAAACTGAGAAGCTGAT GTTTTCCACATATTTCATGGATTTGTGGAACCTTTTCCAGCCTAAACTTTCTGAGCCAGCAATAGCTACAAATCACAATAAACAGGCTTT GCTTTCATTTTGGTACAATGTCTGTGCTGACTGTCCAGAGAATATCCGCCTTATTGTTCAGAACCCAGTGGTAACCAAGAACATTGCCTT CAATTACATCCTTGCTGACCATGATGATCAGGATGTGGTGCTTTTTAACCGTGGGATGCTGCCAGCGTACTATGGCATTCTGAGGCTCTG CTGTGAGCAGTCTCCTGCATTCACACGACAACTGGCTTCTCACCAGAACATCCAGTGGGCCTTTAAGAATCTTACACCACATGCCAGCCA ATACCCTGGAGCAGTAGAAGAACTGTTTAACCTGATGCAGCTGTTTATAGCTCAGAGGCCAGATATGAGAGAAGAAGAATTAGAAGATAT TAAACAGTTCAAGAAAACAACCATAAGTTGTTACTTACGTTGCTTAGATGGCCGCTCCTGCTGGACTACTTTAATAAGTGCCTTCAGAAT ACTATTAGAATCTGATGAAGACAGACTTCTTGTTGTATTTAATCGAGGATTGATTCTAATGACAGAGTCTTTCAACACTTTGCACATGAT GTATCACGAAGCTACAGCTTGCCATGTGACTGGAGATTTAGTAGAACTTCTGTCAATATTTCTTTCGGTTTTGAAGTCTACACGCCCTTA TCTTCAGAGAAAAGATGTGAAACAAGCATTAATCCAGTGGCAGGAGCGAATTGAATTTGCCCATAAACTGTTAACTCTTCTTAATTCCTA TAGTCCTCCAGAACTTAGAAATGCCTGTATAGATGTCCTCAAGGAACTTGTACTTTTGAGTCCCCATGATTTTCTTCATACTCTGGTTCC CTTTCTACAACACAACCATTGTACTTACCATCACAGTAATATACCAATGTCTCTTGGACCTTATTTCCCTTGTCGAGAAAATATCAAGCT AATAGGAGGGAAAAGCAATATTCGGCCTCCGCGCCCTGAACTCAATATGTGCCTCTTGCCCACAATGGTGGAAACCAGTAAGGGCAAAGA TGACGTTTATGATCGTATGCTGCTAGACTACTTCTTTTCTTATCATCAGTTCATCCATCTATTATGCCGAGTTGCAATCAACTGTGAAAA ATTTACTGAAACATTAGTTAAGCTGAGTGTCCTAGTTGCCTATGAAGGTTTGCCACTTCATCTTGCACTGTTCCCCAAACTTTGGACTGA GCTATGCCAGACTCAGTCTGCTATGTCAAAAAACTGCATCAAGCTTTTGTGTGAAGATCCTGTTTTCGCAGAATATATTAAATGTATCCT AATGGATGAAAGAACTTTTTTAAACAACAACATTGTCTACACGTTCATGACACATTTCCTTCTAAAGGTTCAAAGTCAAGTGTTTTCTGA AGCAAACTGTGCCAATTTGATCAGCACTCTTATTACAAACTTGATAAGCCAGTATCAGAACCTACAGTCTGATTTCTCCAACCGAGTTGA AATTTCCAAAGCAAGTGCTTCTTTAAATGGGGACCTGAGGGCACTCGCTTTGCTCCTGTCAGTACACACTCCCAAACAGTTAAACCCAGC TCTAATTCCAACTCTGCAAGAGCTTTTAAGCAAATGCAGGACTTGTCTGCAACAGAGAAACTCACTCCAAGAGCAAGAAGCCAAAGAAAG AAAAACTAAAGATGATGAAGGAGCAACTCCCATTAAAAGGCGGCGTGTTAGCAGTGATGAGGAGCACACTGTAGACAGCTGCATCAGTGA CATGAAAACAGAAACCAGGGAGGTCCTGACCCCAACGAGCACTTCTGACAATGAGACCAGAGACTCCTCAATTATTGATCCAGGAACTGA GCAAGATCTTCCTTCCCCTGAAAATAGTTCTGTTAAAGAATACCGAATGGAAGTTCCATCTTCGTTTTCAGAAGACATGTCAAATATCAG GTCACAGCATGCAGAAGAACAGTCCAACAATGGTAGATATGACGATTGTAAAGAATTTAAAGACCTCCACTGTTCCAAGGATTCTACCCT AGCTGAGGAAGAATCTGAGTTCCCTTCTACTTCTATCTCTGCAGTTCTGTCTGACTTAGCTGACTTGAGAAGCTGTGATGGCCAAGCTTT GCCCTCCCAGGACCCTGAGGTTGCTTTATCTCTCAGTTGTGGCCATTCCAGAGGACTCTTTAGTCATATGCAGCAACATGACATTTTAGA TACCCTGTGTAGGACCATTGAATCTACAATCCATGTCGTCACAAGGATATCTGGCAAAGGAAACCAAGCTGCTTCTTGACATTAGGTGTA GCATGTCTACTTTTAAGTCCCTCACCCCCAACCCCCATGCTGTTTGTATAAGTTTTGCTTATTTGTTTTTGTGCTTCAGTTTGTCCAGTG CTCTCTGCTTGAATGGCAAGATAGATTTATAGGCTTAATTCTTGGTCAGGCAGAACTCCAGATGAAAAAAACTTGCATCTTCAGTATACT TCCTAAAGGGCAATCAGATAATGGATATGTTTTATGTAATTAAGAGTTCACTTTAGTGGCTTTCATTTAATATGGCTGTCTGGGAAGAAC AGGGTTGCCTAGCCCTGTACAATGTAATTTAAACTTACAGCATTTTTACTGTGTATGATATGGTGTCCTCTGTGCCAGTTTTGTACCTTA TAGAGGCAGATTGCCTCCGATCGCTGTGGTTCTTATTATCAAAATTAAGTTTACTTGTATACGGAACAACCACAAGAAATTTGATTCTGT AAAGAATCCTCTTTAGCTGTGGCCTGGCAGTATATAAATGGTGCTTTATTTAACAGAATACCTGTGGAGGAAATAAAGCACACTTGATGT >95945_95945_1_UBAP2-USP34_UBAP2_chr9_34017048_ENST00000379238_USP34_chr2_61512092_ENST00000398571_length(amino acids)=2001AA_BP=38 MYILYMMTSVSSDHCRGAREKPQISAAQSTQPQKQVVQVFLVLVQGTSLIQRLMSVAYTYDNLAPRVLKAQSDHRSRHEVSHYSMWLLVS WAHCCSLVKSSLADSDHLQDWLKKLTLLIPETAVRHESCSGLYKLSLSGLDGGDSINRSFLLLAASTLLKFLPDAQALKPIRIDDYEEEP ILKPGCKEYFWLLCKLVDNIHIKDASQTTLLDLDALARHLADCIRSREILDHQDGNVEDDGLTGLLRLATSVVKHKPPFKFSREGQEFLR DIFNLLFLLPSLKDRQQPKCKSHSSRAAAYDLLVEMVKGSVENYRLIHNWVMAQHMQSHAPYKWDYWPHEDVRAECRFVGLTNLGATCYL ASTIQQLYMIPEARQAVFTAKYSEDMKHKTTLLELQKMFTYLMESECKAYNPRPFCKTYTMDKQPLNTGEQKDMTEFFTDLITKIEEMSP ELKNTVKSLFGGVITNNVVSLDCEHVSQTAEEFYTVRCQVADMKNIYESLDEVTIKDTLEGDNMYTCSHCGKKVRAEKRACFKKLPRILS FNTMRYTFNMVTMMKEKVNTHFSFPLRLDMTPYTEDFLMGKSERKEGFKEVSDHSKDSESYEYDLIGVTVHTGTADGGHYYSFIRDIVNP HAYKNNKWYLFNDAEVKPFDSAQLASECFGGEMTTKTYDSVTDKFMDFSFEKTHSAYMLFYKRMEPEEENGREYKFDVSSELLEWIWHDN MQFLQDKNIFEHTYFGFMWQLCSCIPSTLPDPKAVSLMTAKLSTSFVLETFIHSKEKPTMLQWIELLTKQFNNSQAACEWFLDRMADDDW WPMQILIKCPNQIVRQMFQRLCIHVIQRLRPVHAHLYLQPGMEDGSDDMDTSVEDIGGRSCVTRFVRTLLLIMEHGVKPHSKHLTEYFAF LYEFAKMGEEESQFLLSLQAISTMVHFYMGTKGPENPQVEVLSEEEGEEEEEEEDILSLAEEKYRPAALEKMIALVALLVEQSRSERHLT LSQTDMAALTGGKGFPFLFQHIRDGINIRQTCNLIFSLCRYNNRLAEHIVSMLFTSIAKLTPEAANPFFKLLTMLMEFAGGPPGMPPFAS YILQRIWEVIEYNPSQCLDWLAVQTPRNKLAHSWVLQNMENWVERFLLAHNYPRVRTSAAYLLVSLIPSNSFRQMFRSTRSLHIPTRDLP LSPDTTVVLHQVYNVLLGLLSRAKLYVDAAVHGTTKLVPYFSFMTYCLISKTEKLMFSTYFMDLWNLFQPKLSEPAIATNHNKQALLSFW YNVCADCPENIRLIVQNPVVTKNIAFNYILADHDDQDVVLFNRGMLPAYYGILRLCCEQSPAFTRQLASHQNIQWAFKNLTPHASQYPGA VEELFNLMQLFIAQRPDMREEELEDIKQFKKTTISCYLRCLDGRSCWTTLISAFRILLESDEDRLLVVFNRGLILMTESFNTLHMMYHEA TACHVTGDLVELLSIFLSVLKSTRPYLQRKDVKQALIQWQERIEFAHKLLTLLNSYSPPELRNACIDVLKELVLLSPHDFLHTLVPFLQH NHCTYHHSNIPMSLGPYFPCRENIKLIGGKSNIRPPRPELNMCLLPTMVETSKGKDDVYDRMLLDYFFSYHQFIHLLCRVAINCEKFTET LVKLSVLVAYEGLPLHLALFPKLWTELCQTQSAMSKNCIKLLCEDPVFAEYIKCILMDERTFLNNNIVYTFMTHFLLKVQSQVFSEANCA NLISTLITNLISQYQNLQSDFSNRVEISKASASLNGDLRALALLLSVHTPKQLNPALIPTLQELLSKCRTCLQQRNSLQEQEAKERKTKD DEGATPIKRRRVSSDEEHTVDSCISDMKTETREVLTPTSTSDNETRDSSIIDPGTEQDLPSPENSSVKEYRMEVPSSFSEDMSNIRSQHA EEQSNNGRYDDCKEFKDLHCSKDSTLAEEESEFPSTSISAVLSDLADLRSCDGQALPSQDPEVALSLSCGHSRGLFSHMQQHDILDTLCR -------------------------------------------------------------- >95945_95945_2_UBAP2-USP34_UBAP2_chr9_34017048_ENST00000449054_USP34_chr2_61512092_ENST00000398571_length(transcript)=6732nt_BP=201nt ATTGGCAGGTAACGAGCGGCGGCGGCGGCAGCGGGTCTTGGGTCCTCCGAGAGCAGCAGCGATTTTCTATTTTGTACATACATTATTTTG TATATACTGTATATGATGACTTCAGTGAGCAGTGACCATTGTCGAGGTGCTCGGGAAAAACCACAGATTTCAGCAGCACAATCAACGCAA CCACAGAAACAAGTGGTACAGGTATTTCTTGTTCTTGTCCAAGGAACCAGTTTGATTCAGCGACTTATGTCTGTTGCTTATACGTATGAT AATCTGGCTCCTAGAGTTTTAAAAGCTCAGTCTGATCACAGGTCTAGACATGAAGTTTCACATTATTCAATGTGGCTCTTGGTGAGTTGG GCTCATTGCTGTTCTTTAGTGAAATCTAGCCTTGCTGATAGCGATCATTTACAAGATTGGCTAAAGAAATTGACTCTCCTTATTCCTGAG ACTGCAGTTCGTCATGAATCATGCAGTGGTCTCTATAAGTTATCCCTGTCAGGGCTGGATGGAGGAGACTCAATCAATCGTTCTTTTCTG CTATTGGCTGCCTCAACATTATTGAAATTTCTTCCTGATGCTCAAGCACTCAAACCTATTAGGATAGATGATTATGAGGAAGAACCAATA TTAAAACCAGGATGTAAAGAGTATTTTTGGTTGTTATGCAAATTAGTTGACAACATACATATAAAGGACGCTAGTCAGACAACGCTCCTC GACTTAGATGCCTTGGCAAGACATTTGGCTGACTGTATTCGAAGTAGGGAGATCCTTGATCATCAGGATGGTAATGTAGAAGATGATGGG CTTACAGGACTCCTAAGGCTTGCAACAAGTGTTGTTAAACACAAACCACCCTTTAAATTTTCAAGGGAAGGACAGGAATTTTTGAGAGAT ATCTTCAATCTCCTGTTTTTGTTGCCAAGTCTAAAGGACCGACAACAGCCAAAGTGCAAATCACATTCTTCAAGAGCTGCCGCTTACGAT TTGTTAGTAGAGATGGTAAAGGGGTCTGTTGAGAACTACAGGCTAATACACAACTGGGTTATGGCACAACACATGCAGTCCCATGCACCT TATAAATGGGATTACTGGCCTCATGAAGATGTCCGTGCTGAATGTAGATTTGTTGGCCTTACTAACCTTGGAGCTACTTGTTACTTAGCT TCTACTATTCAGCAACTTTATATGATACCTGAGGCAAGACAGGCTGTCTTCACTGCCAAGTATTCAGAGGATATGAAGCACAAGACCACT CTTCTGGAGCTTCAGAAAATGTTTACATATTTAATGGAGAGTGAATGCAAAGCATATAATCCTAGACCTTTCTGTAAAACATACACCATG GATAAGCAGCCTCTGAATACTGGGGAACAGAAAGATATGACAGAGTTTTTTACTGATCTAATTACCAAAATCGAAGAAATGTCTCCCGAA CTGAAAAATACCGTCAAAAGTTTATTTGGAGGTGTAATTACAAACAATGTTGTATCCTTGGATTGTGAACATGTTAGTCAAACTGCTGAA GAGTTTTATACTGTGAGGTGCCAAGTGGCTGATATGAAGAACATTTATGAATCTCTTGATGAAGTTACTATAAAAGACACTTTGGAAGGT GATAACATGTATACTTGTTCTCATTGTGGGAAGAAAGTACGAGCTGAAAAAAGGGCATGTTTTAAGAAATTGCCTCGCATTTTGAGTTTC AATACTATGAGATACACATTTAATATGGTCACGATGATGAAAGAGAAAGTGAATACACACTTTTCCTTCCCATTACGTTTGGACATGACG CCCTATACAGAAGATTTTCTTATGGGAAAGAGTGAGAGGAAAGAAGGTTTTAAAGAAGTCAGTGATCATTCAAAAGACTCAGAGAGCTAT GAATATGACTTGATAGGAGTGACTGTTCACACAGGAACGGCAGATGGTGGACACTATTATAGCTTTATCAGAGATATAGTAAATCCCCAT GCTTATAAAAACAATAAATGGTATCTTTTTAATGATGCTGAGGTAAAACCTTTTGATTCTGCTCAACTTGCATCTGAATGTTTTGGTGGA GAGATGACGACCAAGACCTATGATTCTGTTACAGATAAATTTATGGACTTCTCTTTTGAAAAGACACACAGTGCATATATGCTGTTTTAC AAACGCATGGAACCAGAGGAAGAAAATGGCAGAGAATACAAATTTGATGTTTCGTCAGAGTTACTAGAGTGGATTTGGCATGATAACATG CAGTTTCTTCAAGACAAAAACATTTTTGAACATACATATTTTGGATTTATGTGGCAATTGTGTAGTTGTATTCCCAGTACATTACCAGAT CCTAAAGCTGTGTCCTTAATGACAGCAAAGTTAAGCACTTCCTTTGTCCTAGAGACATTTATTCATTCTAAAGAAAAGCCCACGATGCTT CAGTGGATTGAACTGTTGACGAAACAGTTTAATAATAGTCAGGCAGCTTGTGAGTGGTTTTTAGATCGTATGGCTGATGACGACTGGTGG CCAATGCAGATACTAATTAAGTGCCCTAATCAAATTGTGAGACAGATGTTTCAGCGTTTGTGTATCCATGTGATTCAGAGGCTGAGACCT GTGCATGCTCATCTCTATTTGCAGCCAGGAATGGAAGATGGGTCAGATGATATGGATACCTCAGTAGAAGATATTGGTGGTCGTTCATGT GTCACTCGCTTTGTGAGAACCCTGTTATTAATTATGGAACATGGTGTAAAACCTCACAGTAAACATCTTACAGAGTATTTTGCCTTCCTT TACGAATTTGCAAAAATGGGTGAAGAAGAGAGCCAATTTTTGCTTTCATTGCAAGCTATATCTACAATGGTACATTTTTACATGGGAACA AAAGGACCTGAAAATCCTCAAGTTGAAGTGTTATCAGAGGAAGAAGGGGAAGAAGAAGAGGAGGAAGAAGATATCCTCTCTCTGGCAGAA GAAAAATACAGGCCAGCTGCCCTTGAAAAGATGATAGCTTTAGTTGCTCTTTTGGTTGAACAGTCTCGATCAGAAAGGCATTTGACATTA TCACAGACTGACATGGCAGCATTAACAGGAGGAAAGGGATTTCCCTTCTTGTTTCAACATATTCGTGATGGCATCAATATAAGACAAACT TGTAATCTGATTTTCAGCCTGTGTCGATACAATAATCGACTTGCAGAACATATTGTATCTATGCTTTTCACATCAATAGCAAAGTTGACT CCTGAGGCAGCCAATCCTTTCTTTAAGTTGTTGACTATGCTAATGGAGTTTGCTGGTGGACCTCCAGGAATGCCTCCCTTTGCATCTTAT ATTCTGCAGAGGATATGGGAGGTGATTGAATACAATCCTTCTCAGTGTCTAGATTGGTTGGCAGTGCAGACACCCCGAAATAAACTGGCA CACAGCTGGGTCTTACAGAATATGGAAAACTGGGTCGAGCGGTTTCTTTTGGCTCACAATTATCCTAGAGTGAGGACTTCTGCAGCTTAT CTTCTGGTGTCCCTTATACCAAGCAATTCATTCCGTCAGATGTTCCGGTCAACAAGGTCTTTGCACATCCCAACCCGTGACCTTCCACTC AGTCCAGACACAACAGTAGTCCTACATCAGGTCTACAACGTGCTCCTTGGTTTGCTCTCAAGAGCCAAACTTTATGTTGATGCTGCTGTT CATGGCACTACAAAGCTAGTGCCCTATTTTAGCTTTATGACTTACTGTTTAATTTCCAAAACTGAGAAGCTGATGTTTTCCACATATTTC ATGGATTTGTGGAACCTTTTCCAGCCTAAACTTTCTGAGCCAGCAATAGCTACAAATCACAATAAACAGGCTTTGCTTTCATTTTGGTAC AATGTCTGTGCTGACTGTCCAGAGAATATCCGCCTTATTGTTCAGAACCCAGTGGTAACCAAGAACATTGCCTTCAATTACATCCTTGCT GACCATGATGATCAGGATGTGGTGCTTTTTAACCGTGGGATGCTGCCAGCGTACTATGGCATTCTGAGGCTCTGCTGTGAGCAGTCTCCT GCATTCACACGACAACTGGCTTCTCACCAGAACATCCAGTGGGCCTTTAAGAATCTTACACCACATGCCAGCCAATACCCTGGAGCAGTA GAAGAACTGTTTAACCTGATGCAGCTGTTTATAGCTCAGAGGCCAGATATGAGAGAAGAAGAATTAGAAGATATTAAACAGTTCAAGAAA ACAACCATAAGTTGTTACTTACGTTGCTTAGATGGCCGCTCCTGCTGGACTACTTTAATAAGTGCCTTCAGAATACTATTAGAATCTGAT GAAGACAGACTTCTTGTTGTATTTAATCGAGGATTGATTCTAATGACAGAGTCTTTCAACACTTTGCACATGATGTATCACGAAGCTACA GCTTGCCATGTGACTGGAGATTTAGTAGAACTTCTGTCAATATTTCTTTCGGTTTTGAAGTCTACACGCCCTTATCTTCAGAGAAAAGAT GTGAAACAAGCATTAATCCAGTGGCAGGAGCGAATTGAATTTGCCCATAAACTGTTAACTCTTCTTAATTCCTATAGTCCTCCAGAACTT AGAAATGCCTGTATAGATGTCCTCAAGGAACTTGTACTTTTGAGTCCCCATGATTTTCTTCATACTCTGGTTCCCTTTCTACAACACAAC CATTGTACTTACCATCACAGTAATATACCAATGTCTCTTGGACCTTATTTCCCTTGTCGAGAAAATATCAAGCTAATAGGAGGGAAAAGC AATATTCGGCCTCCGCGCCCTGAACTCAATATGTGCCTCTTGCCCACAATGGTGGAAACCAGTAAGGGCAAAGATGACGTTTATGATCGT ATGCTGCTAGACTACTTCTTTTCTTATCATCAGTTCATCCATCTATTATGCCGAGTTGCAATCAACTGTGAAAAATTTACTGAAACATTA GTTAAGCTGAGTGTCCTAGTTGCCTATGAAGGTTTGCCACTTCATCTTGCACTGTTCCCCAAACTTTGGACTGAGCTATGCCAGACTCAG TCTGCTATGTCAAAAAACTGCATCAAGCTTTTGTGTGAAGATCCTGTTTTCGCAGAATATATTAAATGTATCCTAATGGATGAAAGAACT TTTTTAAACAACAACATTGTCTACACGTTCATGACACATTTCCTTCTAAAGGTTCAAAGTCAAGTGTTTTCTGAAGCAAACTGTGCCAAT TTGATCAGCACTCTTATTACAAACTTGATAAGCCAGTATCAGAACCTACAGTCTGATTTCTCCAACCGAGTTGAAATTTCCAAAGCAAGT GCTTCTTTAAATGGGGACCTGAGGGCACTCGCTTTGCTCCTGTCAGTACACACTCCCAAACAGTTAAACCCAGCTCTAATTCCAACTCTG CAAGAGCTTTTAAGCAAATGCAGGACTTGTCTGCAACAGAGAAACTCACTCCAAGAGCAAGAAGCCAAAGAAAGAAAAACTAAAGATGAT GAAGGAGCAACTCCCATTAAAAGGCGGCGTGTTAGCAGTGATGAGGAGCACACTGTAGACAGCTGCATCAGTGACATGAAAACAGAAACC AGGGAGGTCCTGACCCCAACGAGCACTTCTGACAATGAGACCAGAGACTCCTCAATTATTGATCCAGGAACTGAGCAAGATCTTCCTTCC CCTGAAAATAGTTCTGTTAAAGAATACCGAATGGAAGTTCCATCTTCGTTTTCAGAAGACATGTCAAATATCAGGTCACAGCATGCAGAA GAACAGTCCAACAATGGTAGATATGACGATTGTAAAGAATTTAAAGACCTCCACTGTTCCAAGGATTCTACCCTAGCTGAGGAAGAATCT GAGTTCCCTTCTACTTCTATCTCTGCAGTTCTGTCTGACTTAGCTGACTTGAGAAGCTGTGATGGCCAAGCTTTGCCCTCCCAGGACCCT GAGGTTGCTTTATCTCTCAGTTGTGGCCATTCCAGAGGACTCTTTAGTCATATGCAGCAACATGACATTTTAGATACCCTGTGTAGGACC ATTGAATCTACAATCCATGTCGTCACAAGGATATCTGGCAAAGGAAACCAAGCTGCTTCTTGACATTAGGTGTAGCATGTCTACTTTTAA GTCCCTCACCCCCAACCCCCATGCTGTTTGTATAAGTTTTGCTTATTTGTTTTTGTGCTTCAGTTTGTCCAGTGCTCTCTGCTTGAATGG CAAGATAGATTTATAGGCTTAATTCTTGGTCAGGCAGAACTCCAGATGAAAAAAACTTGCATCTTCAGTATACTTCCTAAAGGGCAATCA GATAATGGATATGTTTTATGTAATTAAGAGTTCACTTTAGTGGCTTTCATTTAATATGGCTGTCTGGGAAGAACAGGGTTGCCTAGCCCT GTACAATGTAATTTAAACTTACAGCATTTTTACTGTGTATGATATGGTGTCCTCTGTGCCAGTTTTGTACCTTATAGAGGCAGATTGCCT CCGATCGCTGTGGTTCTTATTATCAAAATTAAGTTTACTTGTATACGGAACAACCACAAGAAATTTGATTCTGTAAAGAATCCTCTTTAG CTGTGGCCTGGCAGTATATAAATGGTGCTTTATTTAACAGAATACCTGTGGAGGAAATAAAGCACACTTGATGTAAAAATAATTGTTTTA >95945_95945_2_UBAP2-USP34_UBAP2_chr9_34017048_ENST00000449054_USP34_chr2_61512092_ENST00000398571_length(amino acids)=2001AA_BP=38 MYILYMMTSVSSDHCRGAREKPQISAAQSTQPQKQVVQVFLVLVQGTSLIQRLMSVAYTYDNLAPRVLKAQSDHRSRHEVSHYSMWLLVS WAHCCSLVKSSLADSDHLQDWLKKLTLLIPETAVRHESCSGLYKLSLSGLDGGDSINRSFLLLAASTLLKFLPDAQALKPIRIDDYEEEP ILKPGCKEYFWLLCKLVDNIHIKDASQTTLLDLDALARHLADCIRSREILDHQDGNVEDDGLTGLLRLATSVVKHKPPFKFSREGQEFLR DIFNLLFLLPSLKDRQQPKCKSHSSRAAAYDLLVEMVKGSVENYRLIHNWVMAQHMQSHAPYKWDYWPHEDVRAECRFVGLTNLGATCYL ASTIQQLYMIPEARQAVFTAKYSEDMKHKTTLLELQKMFTYLMESECKAYNPRPFCKTYTMDKQPLNTGEQKDMTEFFTDLITKIEEMSP ELKNTVKSLFGGVITNNVVSLDCEHVSQTAEEFYTVRCQVADMKNIYESLDEVTIKDTLEGDNMYTCSHCGKKVRAEKRACFKKLPRILS FNTMRYTFNMVTMMKEKVNTHFSFPLRLDMTPYTEDFLMGKSERKEGFKEVSDHSKDSESYEYDLIGVTVHTGTADGGHYYSFIRDIVNP HAYKNNKWYLFNDAEVKPFDSAQLASECFGGEMTTKTYDSVTDKFMDFSFEKTHSAYMLFYKRMEPEEENGREYKFDVSSELLEWIWHDN MQFLQDKNIFEHTYFGFMWQLCSCIPSTLPDPKAVSLMTAKLSTSFVLETFIHSKEKPTMLQWIELLTKQFNNSQAACEWFLDRMADDDW WPMQILIKCPNQIVRQMFQRLCIHVIQRLRPVHAHLYLQPGMEDGSDDMDTSVEDIGGRSCVTRFVRTLLLIMEHGVKPHSKHLTEYFAF LYEFAKMGEEESQFLLSLQAISTMVHFYMGTKGPENPQVEVLSEEEGEEEEEEEDILSLAEEKYRPAALEKMIALVALLVEQSRSERHLT LSQTDMAALTGGKGFPFLFQHIRDGINIRQTCNLIFSLCRYNNRLAEHIVSMLFTSIAKLTPEAANPFFKLLTMLMEFAGGPPGMPPFAS YILQRIWEVIEYNPSQCLDWLAVQTPRNKLAHSWVLQNMENWVERFLLAHNYPRVRTSAAYLLVSLIPSNSFRQMFRSTRSLHIPTRDLP LSPDTTVVLHQVYNVLLGLLSRAKLYVDAAVHGTTKLVPYFSFMTYCLISKTEKLMFSTYFMDLWNLFQPKLSEPAIATNHNKQALLSFW YNVCADCPENIRLIVQNPVVTKNIAFNYILADHDDQDVVLFNRGMLPAYYGILRLCCEQSPAFTRQLASHQNIQWAFKNLTPHASQYPGA VEELFNLMQLFIAQRPDMREEELEDIKQFKKTTISCYLRCLDGRSCWTTLISAFRILLESDEDRLLVVFNRGLILMTESFNTLHMMYHEA TACHVTGDLVELLSIFLSVLKSTRPYLQRKDVKQALIQWQERIEFAHKLLTLLNSYSPPELRNACIDVLKELVLLSPHDFLHTLVPFLQH NHCTYHHSNIPMSLGPYFPCRENIKLIGGKSNIRPPRPELNMCLLPTMVETSKGKDDVYDRMLLDYFFSYHQFIHLLCRVAINCEKFTET LVKLSVLVAYEGLPLHLALFPKLWTELCQTQSAMSKNCIKLLCEDPVFAEYIKCILMDERTFLNNNIVYTFMTHFLLKVQSQVFSEANCA NLISTLITNLISQYQNLQSDFSNRVEISKASASLNGDLRALALLLSVHTPKQLNPALIPTLQELLSKCRTCLQQRNSLQEQEAKERKTKD DEGATPIKRRRVSSDEEHTVDSCISDMKTETREVLTPTSTSDNETRDSSIIDPGTEQDLPSPENSSVKEYRMEVPSSFSEDMSNIRSQHA EEQSNNGRYDDCKEFKDLHCSKDSTLAEEESEFPSTSISAVLSDLADLRSCDGQALPSQDPEVALSLSCGHSRGLFSHMQQHDILDTLCR -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for UBAP2-USP34 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for UBAP2-USP34 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for UBAP2-USP34 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies